Evidence map›Paper›PMID 19331832›Full record

ArticleExperimental cell research2009

Prosurvival Bcl-2 proteins stabilize pancreatic mitochondria and protect against necrosis in experimental pancreatitis.

Kai-Feng Sung, Irina V Odinokova, Olga A Mareninova, Zoltán Rakonczay, Péter Hegyi, Stephen J Pandol, Ilya Gukovsky, Anna S Gukovskaya

Abstract read
In one paragraph

Article in Experimental cell research, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
7.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 78 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Review
  5. The role of Interleukin-22 in severe acute pancreatitis.Molecular medicine (Cambridge, Mass.) · 2024
    Review
  6. Review
  7. Article
  8. Protein kinase D: A therapeutic target in experimental alcoholic pancreatitis.Biochimica et biophysica acta. Molecular basis of disease · 2022
    Article
  9. Article
  10. Role of Interleukin-17 in Acute Pancreatitis.Frontiers in immunology · 2021
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 4 countries.

Kai-Feng SungVeterans Affairs Greater Los Angeles Healthcare System, Los Angeles, CA, USA.
Irina V Odinokova
Olga A Mareninova
Zoltán Rakonczay
Péter Hegyi
Stephen J Pandol
Ilya Gukovsky
Anna S Gukovskaya
University of California, Los Angeles · USVA Greater Los Angeles Healthcare System · USUniversity of Szeged · HU

Funding

Apoptosis and Necrosis in PancreatitisR01DK059936 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI GUKOVSKAYA, ANNA S. · 2003 to 2012
$2.1M
NIDDK NIH HHS DK59936NIDDK NIH HHS R01 DK059936
6 · The paper itself

Abstract

Acinar cells in pancreatitis die through apoptosis and necrosis, the roles of which are different. The severity of experimental pancreatitis correlates directly with the extent of necrosis and inversely, with apoptosis. Apoptosis is mediated by the release of cytochrome c into the cytosol followed by caspase activation, whereas necrosis is associated with the mitochondrial membrane potential (DeltaPsim) loss leading to ATP depletion. Here, we investigate the role of Bcl-2 proteins in apoptosis and necrosis in pancreatitis. We found up-regulation of prosurvival Bcl-2 proteins in pancreas in various experimental models of acute pancreatitis, most pronounced for Bcl-xL. This up-regulation translated into increased levels of Bcl-xL and Bcl-2 in pancreatic mitochondria. Bcl-xL/Bcl-2 inhibitors induced DeltaPsim loss and cytochrome c release in isolated mitochondria. Corroborating the results on mitochondria, Bcl-xL/Bcl-2 inhibitors induced DeltaPsim loss, ATP depletion and necrosis in pancreatic acinar cells, both untreated and hyperstimulated with CCK-8 (in vitro pancreatitis model). Together Bcl-xL/Bcl-2 inhibitors and CCK induced more necrosis than either treatment alone. Bcl-xL/Bcl-2 inhibitors also stimulated cytochrome c release in acinar cells leading to caspase-3 activation and apoptosis. However, different from their effect on pronecrotic signals, the stimulation by Bcl-xL/Bcl-2 inhibitors of apoptotic responses was less in CCK-treated than control cells. Therefore, Bcl-xL/Bcl-2 inhibitors potentiated CCK-induced necrosis but not apoptosis. Correspondingly, transfection with Bcl-xL siRNA stimulated necrosis but not apoptosis in the in vitro pancreatitis model. Further, in animal models of pancreatitis Bcl-xL up-regulation inversely correlated with necrosis, but not apoptosis. Results indicate that Bcl-xL and Bcl-2 protect acinar cells from necrosis in pancreatitis by stabilizing mitochondria against death signals. We conclude that Bcl-xL/Bcl-2 inhibition would aggravate acute pancreatitis, whereas Bcl-xL/Bcl-2 up-regulation presents a strategy to prevent or attenuate necrosis in pancreatitis.

Indexed as

Adenosine TriphosphateAnimalsBase Sequencebcl-X ProteinCapsid ProteinsCaspase 3CeruletideCytochromes cDisease Models, AnimalDNA PrimersGene ExpressionIn Vitro TechniquesMaleMembrane Potential, MitochondrialMiceMitochondriaAdenosine TriphosphateBcl2l1 protein, mouseBcl2l1 protein, ratbcl-X ProteinCapsid ProteinsCasp3 protein, mouseCasp3 protein, ratCaspase 3CeruletideCytochromes cDNA PrimersProto-Oncogene Proteins c-bcl-2RNA, MessengerSincalideVP3 protein, Chicken anemia virus

Identifiers

PMID19331832
PMCPMC4545253
OpenAlexW2021186229

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.